Home » Newsletters » BioWorld

BioWorld

Oct. 27, 1998

View Archived Issues

Other News To Note

UCB Pharma Buys Allergy Applications From CytoMed

Cytogen Gets $12M Equity-Based Credit Line From Irish Investor

Remune, Antiretroviral Combo Passes Phase II Trial In HIV

Watson Buys TheraTech For Stock Worth $300M

Abgenix To Generate Another Antibody Under Pfizer Deal

Megabios, GeneMedicine Agree To 'Strategic Merger' That Pools Gene-Delivery Tech

Candidate Colon Cancer Tumor Suppressor Reveals Embryonic Brain Development Conn

FDA's Hiring 'Pause' Prompts Critical Letter From BIO Head

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026